Navigation Links
Exclusive Interview With Dick Leazer: Renaissance Man

Madison, WI, Jan. 21 - From 1993 through 1999, Dick Leazer served as managing director of the Wisconsin Alumni Research Foundation (WARF), the licensing and commercialization agency of the University of Wisconsin. Since then, he has co-managed the Wisconsin Investment Partners (WIP), an angel investment group based in Madison that focuses on funding life sciences start-ups. Through these two organ......

Full article >>> emanates out from those investments, Wisconsin is a rich environment for economic development. But then there are the issues of equity finance and management talent. We're not at the critical mass yet where we have enough experienced entrepreneurs to really pull these companies together and attract investment dollars. We have the raw materials. We have the science and the laboratories. Now we need......

Full article >>> ogy of the group. Our group really has clicked, and it's been part of our success.

WTN: Why does WIP focus on life science?

DL:. I spent most of my career in the health-care industry in pharmaceuticals and medical devices, and Terry was more in biotech. So, it's a reflection of our backgrounds, and its a reflection of the science on the campus. We go over into the engineer......

Full article >>>
'"/>

Source:wistechnology.com By John D. Grant 02/06/03


Related biology technology :

1. WTN Exclusive Interview: Cory L. Nettles, Secretary of Commerce
2. Epics Founder Judy Faulkner Speaks on Culture, Business Beliefs, and Recruiting: WTN Exclusive Coverage
3. Exclusive WTN Interview with Don Williamson
4. WTN Exclusive Interview with Josh Heling
5. Interview: Dr. William Yasnoff on health records, part 2
6. Interview: Dr. William Yasnoff on patient-centric IT
7. Interview: Dr. Barry Chaiken on healthcare IT
8. Interview: New commerce secretary wants to keep momentum on jobs and business programs
9. Interview: State CIO predicts small businesses and SOA will shape Wisconsin
10. Interview with Medical College of Wisconsin Research Foundations new director of marketing and licensing
11. Federal Health Architecture: An Interview with Kathleen Heuer, HHS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):